Journal article

Retisert (Bausch & Lomb/Control Delivery Systems).

Lyndell L Lim, Justine R Smith, James T Rosenbaum

Curr Opin Investig Drugs | Published : 2005

Abstract

Retisert (Envision TD), a sustained release intraocular implant containing fluocinolone acetonide, has been developed and launched in the US by Bausch & Lomb and Control Delivery Systems for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.